UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
Breakout Stocks: How to trade Laurus Labs, Torrent Pharma and Fortis Healthcare that hit a fresh 52-week high?
Indian market closed in the red for the third consecutive day in a row on Monday. The BSE Sensex fell more than 500 points while